Literature DB >> 20513427

Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis.

Meng Qiao1, Yaqi Wang, Xiaoen Xu, Jing Lu, Yongli Dong, Wufan Tao, Janet Stein, Gary S Stein, James D Iglehart, Qian Shi, Arthur B Pardee.   

Abstract

PHLPP1 and PHLPP2 phosphatases exert their tumor-suppressing functions by dephosphorylation and inactivation of Akt in several breast cancer and glioblastoma cells. However, Akt, or other known targets of PHLPPs that include PKC and ERK, may not fully elucidate the physiological role of the multifunctional phosphatases, especially their powerful apoptosis induction function. Here, we show that PHLPPs induce apoptosis in cancer cells independent of the known targets of PHLPPs. We identified Mst1 as a binding partner that interacts with PHLPPs both in vivo and in vitro. PHLPPs dephosphorylate Mst1 on the T387 inhibitory site, which activate Mst1 and its downstream effectors p38 and JNK to induce apoptosis. The same T387 site can be phosphorylated by Akt. Thus, PHLPP, Akt, and Mst1 constitute an autoinhibitory triangle that controls the fine balance of apoptosis and proliferation that is cell type and context dependent. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513427     DOI: 10.1016/j.molcel.2010.03.017

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  67 in total

1.  Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling.

Authors:  Noel A Warfel; Alexandra C Newton
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

2.  Dimerization and cytoplasmic localization regulate Hippo kinase signaling activity in organ size control.

Authors:  Yunyun Jin; Liang Dong; Yi Lu; Wenqing Wu; Qian Hao; Zhaocai Zhou; Jin Jiang; Yun Zhao; Lei Zhang
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

3.  Suppression of survival signalling pathways by the phosphatase PHLPP.

Authors:  Audrey K O'Neill; Matthew J Niederst; Alexandra C Newton
Journal:  FEBS J       Date:  2012-03-16       Impact factor: 5.542

4.  Redemystifying MST1/hippo signaling.

Authors:  Lei Xiao; Zengqiang Yuan
Journal:  Protein Cell       Date:  2010-08       Impact factor: 14.870

Review 5.  Regulation of mammalian Ste20 (Mst) kinases.

Authors:  Sonali J Rawat; Jonathan Chernoff
Journal:  Trends Biochem Sci       Date:  2015-02-06       Impact factor: 13.807

Review 6.  Turning off AKT: PHLPP as a drug target.

Authors:  Alexandra C Newton; Lloyd C Trotman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

7.  The tumor suppressor Mst1 promotes changes in the cellular redox state by phosphorylation and inactivation of peroxiredoxin-1 protein.

Authors:  Sonali Jalan Rawat; Caretha L Creasy; Jeffrey R Peterson; Jonathan Chernoff
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

8.  PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation.

Authors:  Yanlin Yu; Meng Dai; Andrew Lu; Ellen Yu; Glenn Merlino
Journal:  Oncogene       Date:  2018-02-02       Impact factor: 9.867

9.  The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.

Authors:  Min Chen; Hui Zhang; Zhubing Shi; Yehua Li; Xiaoman Zhang; Ziyang Gao; Li Zhou; Jian Ma; Qi Xu; Jingmin Guan; Yunfeng Cheng; Shi Jiao; Zhaocai Zhou
Journal:  J Biol Chem       Date:  2018-08-02       Impact factor: 5.157

10.  The tuberous sclerosis complex subunit TBC1D7 is stabilized by Akt phosphorylation-mediated 14-3-3 binding.

Authors:  James P Madigan; Feng Hou; Linlei Ye; Jicheng Hu; Aiping Dong; Wolfram Tempel; Marielle E Yohe; Paul A Randazzo; Lisa M Miller Jenkins; Michael M Gottesman; Yufeng Tong
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.